| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 128.312 | 112.984 | 140.887 | 113.437 | 126.164 | 115.972 | 98.610 | 112.634 | 136.338 | 174.680 |
| Total Income - EUR | 128.648 | 114.130 | 145.696 | 119.469 | 126.375 | 160.278 | 122.905 | 112.635 | 184.545 | 174.670 |
| Total Expenses - EUR | 55.954 | 82.813 | 67.502 | 87.215 | 79.870 | 92.017 | 106.115 | 83.833 | 135.155 | 179.450 |
| Gross Profit/Loss - EUR | 72.694 | 31.317 | 78.194 | 32.254 | 46.505 | 68.261 | 16.790 | 28.802 | 49.390 | -4.780 |
| Net Profit/Loss - EUR | 59.665 | 25.544 | 60.608 | 31.059 | 45.241 | 66.658 | 15.709 | 27.732 | 47.582 | -9.391 |
| Employees | 4 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Almed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.019 | 57.619 | 52.041 | 60.738 | 101.852 | 62.016 | 101.577 | 76.431 | 436.820 | 279.753 |
| Current Assets | 127.331 | 68.113 | 101.631 | 102.208 | 116.782 | 158.086 | 159.824 | 123.253 | 23.590 | 6.278 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 747 | 102 |
| Receivables | 124.895 | 65.649 | 95.236 | 99.935 | 113.595 | 154.505 | 148.537 | 120.360 | 21.020 | 5.797 |
| Cash | 2.436 | 2.464 | 6.395 | 2.272 | 3.186 | 3.581 | 11.286 | 2.893 | 1.824 | 379 |
| Shareholders Funds | 63.559 | 29.398 | 64.397 | 77.660 | 93.468 | 135.397 | 136.301 | 117.002 | 51.081 | 8.629 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 42 |
| Debts | 64.791 | 96.334 | 89.276 | 85.285 | 125.166 | 84.705 | 125.099 | 82.682 | 409.329 | 277.401 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Almed Srl